JPS61186247A - Crystallized cao-al2o3-p2o5 glass - Google Patents

Crystallized cao-al2o3-p2o5 glass

Info

Publication number
JPS61186247A
JPS61186247A JP60027318A JP2731885A JPS61186247A JP S61186247 A JPS61186247 A JP S61186247A JP 60027318 A JP60027318 A JP 60027318A JP 2731885 A JP2731885 A JP 2731885A JP S61186247 A JPS61186247 A JP S61186247A
Authority
JP
Japan
Prior art keywords
glass
cao
al2o3
weight
crystallization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60027318A
Other languages
Japanese (ja)
Other versions
JPH0476939B2 (en
Inventor
Akira Watanabe
明 渡辺
Yoshimitsu Takeuchi
武内 祥光
Seiji Kihara
木原 誠治
Makoto Koto
光藤 誠
Shigeo Nanba
難波 茂雄
Yukio Imada
今田 幸生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Krosaki Harima Corp
Original Assignee
Kyushu Refractories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyushu Refractories Co Ltd filed Critical Kyushu Refractories Co Ltd
Priority to JP60027318A priority Critical patent/JPS61186247A/en
Publication of JPS61186247A publication Critical patent/JPS61186247A/en
Publication of JPH0476939B2 publication Critical patent/JPH0476939B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
  • Dental Prosthetics (AREA)
  • Glass Compositions (AREA)

Abstract

PURPOSE:To obtain a three-component crystallized glass having low internal defects and suitable as dental materials and artificial bone materials, etc., by compounding CaO, Al2O3 and P2O5 at specific ratios. CONSTITUTION:The objective glass is obtained by mixing 10-60wt% CaO, 5-25wt% Al2O3 and 25-85wt% P2O5. It can be produced by (1) selecting one or more compounds from each of Ca-containing compounds, P-containing compounds and Al-containing compounds and mixing the components so s to attain the above glass composition, (2) mixing the components throughly with each other and melting by heating at about 1,000-1,700 deg.C, (3) cooling and vitrifying the mixture, and finally (4) properly heat-treating (e.g. at about 600-1,100 deg.C) the glass produced in the step 3.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は歯科材料や人工骨材料等として最適であるリン
酸カルシウム結晶を含有する医用材料に関するものであ
る。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a medical material containing calcium phosphate crystals, which is most suitable as a dental material, an artificial bone material, etc.

〔従来の技術〕[Conventional technology]

近年セラミックの応用範囲の拡大は目ざましく医用分野
にまで通用が及んでおり、従来は金属、プラスチックが
主に使用されて来た医用材料、例えば人工歯根等へもセ
ラミックの応用が試みられている。
In recent years, the range of applications for ceramics has expanded rapidly, reaching the medical field, and efforts are now being made to apply ceramics to medical materials, such as artificial tooth roots, for which metals and plastics have traditionally been used. .

本発明者らは生体に対する親和性を有するセラミック材
料を探し出し、それを任意の形状に自由にかつ高精度に
成形して高強度セラミックを製造する方法に関して研究
を重ねた結果、リン酸カルシウム系材料を素材として選
択することにより、それが可能であることを見出し、そ
れについて鋭意研究を重ねている。
The present inventors searched for a ceramic material that has an affinity for living organisms, and as a result of repeated research into a method for manufacturing high-strength ceramic by freely and highly precisely molding it into any shape, they found that a calcium phosphate-based material was used as a raw material. We have discovered that this is possible by selecting the appropriate method, and have been conducting extensive research on it.

〔発明が解決しようとする問題〕[Problem that the invention seeks to solve]

この優れた特徴を有するリン酸カルシウム系材料も、一
旦ガラス化し結晶化させた際に、ガラスと結晶との比重
差に基づく内部欠陥が発生し、そのため機械的強度が低
下したり、細菌などが侵入しやすくなる。
Even with calcium phosphate materials that have these excellent characteristics, once they are vitrified and crystallized, internal defects occur due to the difference in specific gravity between the glass and the crystals, resulting in a decrease in mechanical strength and the infiltration of bacteria. It becomes easier.

例えば、カルシウムとリンとの原子比Ca / Pカ0
.48のリン酸カルシウムガラスの比重は2.63であ
り、これを熱処理して結晶化するとCaO・P2O5が
生成する。このCaO・P2O5結晶の真比重は2.8
5であり、ガラスの比重よりかなり大きい。ところが結
晶化は表面失透機構で進行するため、結晶化に伴なう体
積減少はほとんどないので、結晶化による比重の増加に
よって、結晶内部には比重の増加に相当する空隙が発生
し、クラ・ツタやボアのような内部欠陥となる。この内
部欠陥のため結晶体の強度は欠陥のないものに比べて低
下してしまうのである。また、ボアなとの発生のa子は
カラスのカルシウムとリンの原子比、結晶化温度、結晶
化時間なとの種々の要因に左右されるため、機械的強度
のバラツキも大きくなることも避けられない。
For example, the atomic ratio of calcium and phosphorus Ca/Pca0
.. The specific gravity of No. 48 calcium phosphate glass is 2.63, and when it is heat-treated and crystallized, CaO.P2O5 is generated. The true specific gravity of this CaO・P2O5 crystal is 2.8
5, which is considerably larger than the specific gravity of glass. However, since crystallization proceeds by a surface devitrification mechanism, there is almost no decrease in volume accompanying crystallization, so as the specific gravity increases due to crystallization, voids corresponding to the increase in specific gravity are generated inside the crystal, and the crystallization - Internal defects such as vines and boas. Because of these internal defects, the strength of the crystal is lower than that of a crystal without defects. In addition, since the atomization of borefish depends on various factors such as the atomic ratio of calcium and phosphorus in the crow, crystallization temperature, and crystallization time, large variations in mechanical strength can be avoided. I can't.

この内部欠陥は、添加物を加えたり、結晶化の方法に工
夫を加えたバルク・クリスタリセーション機構による結
晶化でも結晶化の体積収縮か表面失透機構による場合よ
りや\大きいので内部欠陥の発生する程度は小さいけれ
とも、やはり同様に起こるのである。
Even when crystallization is performed by the bulk crystallization mechanism, which involves adding additives or devising the crystallization method, these internal defects are larger than those caused by the volume shrinkage of crystallization or the surface devitrification mechanism. Although the degree of occurrence is small, it still happens in the same way.

〔問題点を解決するための手段〕[Means for solving problems]

上述の欠点を解消するためには、結晶化前後の比重差を
なくずれはよいわけで、本発明者らはリン酸カルシウム
の生体親和性と結晶化の際の体積収縮の無いという特徴
を損なわすに内部欠陥を生しないような方法について種
々検討した結果、CaO−Al2O3P2O1)3成分
系結晶化カラスを採用することによって、上記問題を解
決することに成功し、本発明を完成するに至ったもので
ある。
In order to eliminate the above-mentioned drawbacks, it is better to eliminate the difference in specific gravity before and after crystallization, and the present inventors have developed a method that does not impair the biocompatibility of calcium phosphate and the characteristics of no volume contraction during crystallization. As a result of various studies on methods that do not cause internal defects, we succeeded in solving the above problem by adopting a three-component crystallized glass (CaO-Al2O3P2O1), and completed the present invention. be.

〔作用] CaO−Al2O3P2O53成分系の組成においてC
aO10〜60重量%、Al2O35〜25重量%、P
 2O625〜85重量%の範囲とする。
[Action] In the composition of the CaO-Al2O3P2O5 3-component system, C
aO10-60% by weight, Al2O35-25% by weight, P
The range is 20625 to 85% by weight.

このガラスを結晶化した場合生成する結晶は、−例をあ
げれは、CaO・P2O5と2Ca○・P2O5および
Al2O3・P2O5であり、その真比重はそれぞれ順
に2.85.3.09、および2.59となっており、
Al2O3・P2O5の比重が他のリン酸カルシウム結
晶よりかなり低いため、他のリン酸カルシウム結晶と混
在すれば結晶中にボアなどの内部欠陥か生じないのであ
る。
When this glass is crystallized, the crystals produced are, for example, CaO.P2O5, 2Ca○.P2O5, and Al2O3.P2O5, and their true specific gravity is 2.85, 3.09, and 2.09, respectively. It is 59,
Since the specific gravity of Al2O3/P2O5 is considerably lower than that of other calcium phosphate crystals, if it is mixed with other calcium phosphate crystals, internal defects such as bores will not occur in the crystal.

例えは、Ca 021.8重量%、Al2O39,3重
量%、P 2O s 68.9重量%の組成のガラスの
比重は2.64であり、このガラスを結晶化させるとそ
の比重は2.67となるが、結晶化の際体積収縮か約0
.5%あるので、ボアの体積は約0.6%となり、内部
欠陥はほとんと無視てきる程度に減少する。
For example, a glass with a composition of 21.8% by weight of Ca, 9.3% by weight of Al2O, and 68.9% by weight of P2Os has a specific gravity of 2.64, and when this glass is crystallized, its specific gravity is 2.67. However, the volume shrinkage during crystallization is approximately 0.
.. 5%, the bore volume is approximately 0.6%, and internal defects are reduced to an almost negligible level.

上記Al2O3・P2O5結晶生成による効果は上述し
たリン酸カルシウム系結晶以外のリン酸カルシウム系結
晶が生ずる場合においても同様の効果を生する。
The above-mentioned effects due to the formation of Al2O3.P2O5 crystals are similar even when calcium phosphate-based crystals other than the above-mentioned calcium phosphate-based crystals are generated.

〔発明の構成〕[Structure of the invention]

本発明の出発原料は酸化カルシウムあるいは水酸化カル
シウム、炭酸カルシウム、修酸カルシウムなど焼成によ
ってCaOを生成するカルシウム含有化合物と、リン酸
、ポリリン酸なと同じく焼成によってリンの酸化物を生
成するリン含有化合物およびアルミナ、水酸化アルミニ
ウムなど焼成して酸化アルミニウムとなるようなアルミ
ニウム含有化合物が用いられる。またリン酸カルシウム
、アパタイト類、リン酸アルミニウム、アルミン酸カル
シウムなども使用出来る。
The starting materials of the present invention are calcium-containing compounds that produce CaO when fired, such as calcium oxide, calcium hydroxide, calcium carbonate, and calcium oxalate, and phosphorus-containing compounds that produce phosphorus oxides when fired, such as phosphoric acid and polyphosphoric acid. Compounds and aluminum-containing compounds such as alumina and aluminum hydroxide that become aluminum oxide when fired are used. Also, calcium phosphate, apatites, aluminum phosphate, calcium aluminate, etc. can be used.

カルシウム含有化合物、リン含有化合物及びアルミニウ
ム含有化合物のそれぞれ1種あるいは2種以上を選ひ、
ガラスの組成をCaO10〜6o重量%、Al2O35
〜25重量%、P2o525〜85重量%の範囲なるよ
うにする。
Select one type or two or more of each of a calcium-containing compound, a phosphorus-containing compound, and an aluminum-containing compound,
The composition of the glass is 10 to 6% by weight of CaO, Al2O35
-25% by weight, P2o525-85% by weight.

CaO60重量%以−ヒあるいはP 2O s 25重
量%未満では溶融温度か高くなり、かつカラス化しない
。逆にCaO10重量%未満またはP 2O s 85
重量%以上では溶融温度か低下すると同時にガラス化も
容易になるが、結晶化処理が難しくなり、かつ過剰のリ
ン酸が遊離して化学的に不安定となり好ましくない。一
方アルミナの含有量が25重量%を越えると溶融温度か
高くなり、また5重量%未満とするとAl2O3・P2
O5の結晶が生成しないか生成量か少なく、ボアなどの
内部欠陥の発生が防げないので、これも好ましくない。
If CaO is more than 60% by weight or P 2 O s is less than 25% by weight, the melting temperature will be high and glass will not form. Conversely, less than 10% by weight of CaO or P 2 O s 85
If it exceeds % by weight, the melting temperature decreases and vitrification becomes easy, but the crystallization process becomes difficult and excessive phosphoric acid is liberated, making it chemically unstable, which is not preferable. On the other hand, if the alumina content exceeds 25% by weight, the melting temperature will become high, and if it is less than 5% by weight, Al2O3・P2
This is also undesirable because O5 crystals are not produced or the amount produced is small, and the occurrence of internal defects such as bores cannot be prevented.

本発明のリン酸カルシウム系ガラスは基本的にはCa、
AI及びPの3成分から構成されるが、本発明の方法に
より製造された結晶化ガラスを歯科材料として使用する
場合は、天然の歯牙と全く1 同じ色沢とするために着
色剤成分を加えることも出来る。この着色剤成分はリン
酸カルシウム成分と作用して発色し、その色調は着色剤
成分の種類や組合せ、添加量を変えることによって微妙
に調整することか出来る。 着色剤成分を加える場合に
はZn、  Fe、 Mn、 W、 Ce、 Ti、 
Ni。
The calcium phosphate glass of the present invention basically consists of Ca,
It is composed of three components, AI and P, but when using the crystallized glass produced by the method of the present invention as a dental material, a colorant component is added to give it exactly the same color as natural teeth. You can also do that. This colorant component interacts with the calcium phosphate component to develop color, and the color tone can be subtly adjusted by changing the type, combination, and amount of the colorant components. When adding colorant components, Zn, Fe, Mn, W, Ce, Ti,
Ni.

Co、Cr、Vの酸化物の中から選ばれた1種あるいは
2種以上であり、特に2種以上を組合せることか好まし
い。その添加量はCaO−Al2O3P2O53成分系
酸化物100重量部に対して眠旧〜15重量部とする。
It is one type or two or more types selected from oxides of Co, Cr, and V, and a combination of two or more types is particularly preferable. The amount added is about 15 parts by weight per 100 parts by weight of the CaO-Al2O3P2O5 ternary oxide.

原料配合は秤量後よく混合し、容器に入れ90000以
上、好ましくは1000〜17006Cに加熱して溶融
する。溶融は1800°C以上となるとリン成分の蒸発
が始まるので注意が必要である。
The raw materials are weighed, mixed well, placed in a container, and heated to 90,000 C or more, preferably 1,000 to 17,006 C to melt. Care must be taken when melting at temperatures above 1800°C, as evaporation of the phosphorus component begins.

溶融終了後冷却ガラス化する。続いて再度溶融して鋳造
するのであるが、最初の溶融物を一旦冷却ガラス化せず
、直接鋳造してもよい。本発明のCaO−Al2O3−
P2O53成分系材料の場合には、溶融物の粘性を十分
低く保つことが出来るので、鋳造成形は金属の歯科材料
において行なわれるロストワックス法が適している。鋳
造型の予熱温度は8006C以下、好ましくは2O0〜
800°Cの範囲で鋳造型の材質、ガラス質の組成によ
り適宜選択される。
After the melting is completed, it is cooled and vitrified. Subsequently, it is melted and cast again, but the first melt may be directly cast without being cooled and vitrified. CaO-Al2O3- of the present invention
In the case of materials based on P2O5 components, the lost wax method used for casting metal dental materials is suitable because the viscosity of the melt can be kept sufficiently low. The preheating temperature of the casting mold is 8006C or less, preferably 2O0~
The temperature is appropriately selected within the range of 800°C depending on the material of the casting mold and the composition of the glass.

このようにして鋳造された鋳造物はガラス質である。こ
のガラス質の材料に適切な熱処理を加えて結晶化ガラス
質とすることにより一段と特性を向上させることができ
る。本発明による3成分系結晶化ガラスの結晶化方法は
次の通りである。ロストワックス法等により成形された
成形体は電気炉などの適当な加熱装置中で加熱される。
The casting thus cast is glassy. By applying appropriate heat treatment to this glassy material to make it crystallized glass, the properties can be further improved. The method for crystallizing the three-component crystallized glass according to the present invention is as follows. A molded body formed by a lost wax method or the like is heated in a suitable heating device such as an electric furnace.

この際の加熱温度は融点以下の温度で、好ましくは60
0〜11006Cである。
The heating temperature at this time is below the melting point, preferably 60°C.
It is 0 to 11006C.

〔実施例〕〔Example〕

実施例 1 炭酸カルシウム粉末、アルミナ粉末および正リン酸を最
終組成がCa 021.8重量%、Al2O39,3重
量%、P 2O s 68.9重量%となるように秤量
し、よく混練した後白金ルツボ中1400°Cでlhr
溶融して、3x 4x 30mmに鋳造、冷却ガラス化
した。得られたリン酸カルシウムガラスを電気炉中で7
10°C11C118O保持し結晶化した。
Example 1 Calcium carbonate powder, alumina powder, and orthophosphoric acid were weighed so that the final composition was 21.8% by weight of Ca, 9.3% by weight of Al2O3, and 68.9% by weight of P2Os, and after thorough kneading, platinum was added. lhr at 1400°C in crucible
It was melted, cast into a size of 3x4x30mm, and cooled and vitrified. The obtained calcium phosphate glass was heated in an electric furnace for 7
The temperature was maintained at 10°C, 11C118O, and crystallized.

得られた結晶化ガラスは白色半透明で、その3点曲げ強
さは1850〜2O00kg/cm” ノ範囲テ平均1
900kg/cTIX2であった。結晶体のX線回折の
結果によると、結晶体中にはCaClP2O5とAl2
O3・P2O5が存在した。またガラスの比重は2,6
4、結晶体の比重は2.67とその差は小さく、結晶体
の微細組織を顕微鏡により観察したところボアなとの内
部欠陥はみられなかった。
The obtained crystallized glass is white and semi-transparent, and its three-point bending strength is 1850 to 2000 kg/cm, with an average of 1
It was 900 kg/cTIX2. According to the results of X-ray diffraction of the crystal, CaClP2O5 and Al2 are present in the crystal.
O3/P2O5 was present. Also, the specific gravity of glass is 2.6
4. The specific gravity of the crystal was 2.67, which was a small difference, and when the microstructure of the crystal was observed under a microscope, no internal defects such as bores were found.

比較例 1 炭酸カルシウム粉末、アルミナ粉末および正リン酸を最
終組成かCa 026.5重量%、Al2O32.9重
量%、P 2O s 70.6重量%となるように秤量
し実施例1と同様に溶融、鋳造、結晶化した。
Comparative Example 1 Calcium carbonate powder, alumina powder, and orthophosphoric acid were weighed so that the final composition was 26.5% by weight of Ca, 2.9% by weight of Al2O, and 70.6% by weight of P2Os, and the same procedure as in Example 1 was carried out. Melted, cast, crystallized.

得られた結晶化力゛ラスも白色半透明ではあったが、そ
の3点曲げ強さは50o〜12ookg/c■2トハラ
ッキ、その値も実施例1に比較して小さがった。
The obtained crystallization strength glass was also white and semi-transparent, but its three-point bending strength was 50 to 12 ook kg/c2, which was also smaller than that of Example 1.

結晶体のX線回折の結果によると、結晶体中にはCaO
・P2O5のみが観測されて、Al2O3・P2O5は
存在しなかった。そしてガラスの比重は2.67、結晶
体を粉砕して測定した比重は2.80であって、結晶体
中には約4〜5%のボアが存在した。
According to the results of X-ray diffraction of the crystal, CaO is present in the crystal.
- Only P2O5 was observed, and Al2O3/P2O5 was not present. The specific gravity of the glass was 2.67, and the specific gravity measured by crushing the crystal was 2.80, and approximately 4 to 5% of bores were present in the crystal.

〔発明の効果〕〔Effect of the invention〕

実施例にみられるように、本発明のCaO7Al2O3
  P2O6系結晶化カラスにおいては、結晶化に伴な
うAl2O3・P2O5の生成によってリン酸カルシウ
ム系結晶の結晶化の際の体積収縮を補なうため、結晶化
前後の比重差か小さいので、ボアなどの内部欠陥はみら
れず、機械的強度は非常に犬き(なり、人工歯冠や人工
骨などの生体材料として最適である。
As seen in the examples, CaO7Al2O3 of the present invention
In P2O6 crystallized glass, the volumetric shrinkage during crystallization of calcium phosphate crystals is compensated for by the production of Al2O3 and P2O5 during crystallization, so the difference in specific gravity before and after crystallization is small, so It has no internal defects and has very good mechanical strength, making it ideal as a biomaterial for artificial tooth crowns and artificial bones.

Claims (1)

【特許請求の範囲】[Claims] CaO10〜60重量%、Al_2O_35〜25重量
%、P_2O_525〜85重量%よりなることを特徴
とするCaO−Al_2O_3−P_2O_5系結晶化
ガラス。
A CaO-Al_2O_3-P_2O_5-based crystallized glass characterized by comprising 10 to 60% by weight of CaO, 35 to 25% by weight of Al_2O_, and 525 to 85% by weight of P_2O_5.
JP60027318A 1985-02-13 1985-02-13 Crystallized cao-al2o3-p2o5 glass Granted JPS61186247A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60027318A JPS61186247A (en) 1985-02-13 1985-02-13 Crystallized cao-al2o3-p2o5 glass

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60027318A JPS61186247A (en) 1985-02-13 1985-02-13 Crystallized cao-al2o3-p2o5 glass

Publications (2)

Publication Number Publication Date
JPS61186247A true JPS61186247A (en) 1986-08-19
JPH0476939B2 JPH0476939B2 (en) 1992-12-07

Family

ID=12217730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60027318A Granted JPS61186247A (en) 1985-02-13 1985-02-13 Crystallized cao-al2o3-p2o5 glass

Country Status (1)

Country Link
JP (1) JPS61186247A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5511625A (en) * 1978-07-12 1980-01-26 Hitachi Ltd Multiplying device
JPS5651574A (en) * 1979-10-03 1981-05-09 Ngk Spark Plug Co Ltd Enameled steel sheet
JPS6172652A (en) * 1984-09-14 1986-04-14 Asahi Glass Co Ltd Calcium phosphate-based crystalline glass for dental material

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5511625A (en) * 1978-07-12 1980-01-26 Hitachi Ltd Multiplying device
JPS5651574A (en) * 1979-10-03 1981-05-09 Ngk Spark Plug Co Ltd Enameled steel sheet
JPS6172652A (en) * 1984-09-14 1986-04-14 Asahi Glass Co Ltd Calcium phosphate-based crystalline glass for dental material

Also Published As

Publication number Publication date
JPH0476939B2 (en) 1992-12-07

Similar Documents

Publication Publication Date Title
US4120730A (en) Biocompatible ceramic glass
JPS63270061A (en) Surface modification of inorganic bio-compatible material
JPS60166247A (en) Phosphate glass ceramic material
JPH0469094B2 (en)
JPS6210939B2 (en)
JPH046657B2 (en)
JPS62128947A (en) Cao-al2o3-p2o5 crystallized glass
JPS61186247A (en) Crystallized cao-al2o3-p2o5 glass
JPS6321237A (en) Al2o3-containing cao-p2o5-b2o3-base crystallized glass
JPS6256336A (en) Production of crystallized cao-al2o3-p2o5 glass
JPS6350344A (en) Glass ceramic composition
JPS6236042A (en) Cao-al2o3-p2o5 three-component crystallized glass
JPS60137853A (en) High-strength crystallized glass containing apatite crystal and its production
JPS60131835A (en) Manufacture of calcium phosphate cast body
JPS60221342A (en) High-strength calcium phosphate crystallized glass
JPS6236031A (en) Production of crystallized cao-al2o3-p2o5 glass
JPS6321236A (en) Cao-p2o5-b2o3 crystallized glass
JPS6256337A (en) Production of crystallized glass of ternary component system of cao-al2o3-p2o5
JPH0639031A (en) Bioimplantation material
JPH01115360A (en) Inorganic living body material and preparation thereof
JPS6172638A (en) Production of calcium phosphate-type crystallized glass
JPS6256335A (en) Crystallized cao-al2o3-p2o5 glass
JPS60180931A (en) Low-melting point calcium phosphate glass
JPS60204636A (en) Production of calcium phosphate based dental material
JPS6171044A (en) Production of calcium phosphate type crystallized glass dental molded body

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees